Cargando…
Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
Molecular imaging plays an increasingly important role in the diagnosis and treatment of different malignancies. Radiolabeled probes enable the visualization of the primary tumor as well as the metastases and have been also employed in targeted therapy and theranostic approaches. With breast cancer...
Autores principales: | Heesch, Amelie, Maurer, Jochen, Stickeler, Elmar, Beheshti, Mohsen, Mottaghy, Felix M., Morgenroth, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590199/ https://www.ncbi.nlm.nih.gov/pubmed/33096754 http://dx.doi.org/10.3390/cells9102334 |
Ejemplares similares
-
The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023) -
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
por: Altunay, Betül, et al.
Publicado: (2020) -
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2020) -
Special Issue: Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
por: Beheshti, Mohsen, et al.
Publicado: (2021) -
PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2022)